Lamisil and Rashes - a phase IV clinical study of FDA data
Summary:
Rashes is found among people who take Lamisil, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Lamisil and have Rashes. It is created by eHealthMe based on reports of 13,046 people who have side effects when taking Lamisil from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
13,046 people reported to have side effects when taking Lamisil.
Among them, 916 people (7.02%) have Rashes.
What is Lamisil?
Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 13,652 Lamisil users for its effectiveness, alternative drugs and more.
What is Rashes?
Rashes (redness) is found to be associated with 5,088 drugs and 6,000 conditions by eHealthMe.
Number of Lamisil and Rashes reports submitted per year:

Time on Lamisil when people have Rashes *:
Gender of people who have Rashes when taking Lamisil*:
Age of people who have Rashes when taking Lamisil *:
Common drugs people take besides Lamisil *:
Common side effects people have besides Rashes *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Lamisil and have Rashes?
Check whether Rashes is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Rashes and when was it recovered:
Expand to all the drugs that have ingredients of terbinafine hydrochloride:
- Rashes and drugs with ingredients of terbinafine hydrochloride (1,407 reports)
Alternative drugs to, pros and cons of Lamisil:
- Lamisil (13,652 reports)
Common Lamisil side effects:
- Rashes (redness): 916 reports
- Itching: 743 reports
- Fever: 646 reports
- Fatigue (feeling of tiredness): 599 reports
- Weight decreased: 568 reports
Browse all side effects of Lamisil:
a b c d e f g h i j k l m n o p q r s t u v w x y zRashes treatments and more:
- Rashes (603,829 reports)
COVID vaccines that are related to Rashes:
- Rashes in Moderna COVID Vaccine
- Rashes in Pfizer BioNTech Covid Vaccine
- Rashes in Johnson and Johnson Covid Vaccine
Common drugs associated with Rashes:
- Adapalene: 49,040 reports
- Humira: 32,791 reports
- Prednisone: 31,608 reports
- Methotrexate: 30,738 reports
- Enbrel: 29,268 reports
- Green tea: 21,666 reports
- Aspirin: 20,315 reports
- Revlimid: 15,559 reports
- Dupixent: 14,713 reports
- Orencia: 13,951 reports
All the drugs that are associated with Rashes:
- Rashes (5,088 drugs)
Common conditions associated with Rashes:
- Rheumatoid arthritis: 43,808 reports
- Acne: 29,888 reports
- High blood pressure: 18,830 reports
- Multiple sclerosis: 17,182 reports
- Multiple myeloma: 16,635 reports
All the conditions that are associated with Rashes:
- Rashes (6,000 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on terbinafine hydrochloride (the active ingredients of Lamisil) and Lamisil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rituxan and Extravasation - 2 seconds ago
- Lozol and Nightmares - 3 seconds ago
- Lisinopril and Trelegy Ellipta drug interaction - 4 seconds ago
- Rivaroxaban and Perirenal Haematoma - 10 seconds ago
- Centrum Silver and Deafness Unilateral - 11 seconds ago
- Lamotrigine and Tendon Disorder - 23 seconds ago
- Zopiclone and Vitamin B6 drug interaction - 34 seconds ago
- Prednisone and Elaprase drug interaction - 35 seconds ago
- Carafate and Blood Pressure Fluctuation - 38 seconds ago
- Urinary Tract Disorder and Haemolytic Anaemia - 38 seconds ago